Key result
Short-duration heating at 45 °C increases adherent endothelial cells by ~°C control.
Why the study?
Localized vascular thermal therapy is limited to a few minutes due to transient blood flow occlusion, so the optimal short-duration heating temperature to preserve endothelial cells while suppressing vascular smooth muscle cell proliferation needed to be explored.
Does short-duration heating at 45-55 °C preserve endothelial cells while suppressing vascular smooth muscle cell proliferation compared to 37 °C control in cell and ex vivo tissue models?
Does short-duration heating at 45-55 °C preserve endothelial cells while suppressing vascular smooth muscle cell proliferation compared to 37 °C control in cell and ex vivo tissue models?
Spatially selective short-duration heating (below 45 °C for endothelial cells and above 50 °C for vascular smooth muscle cells) preserves endothelial viability while inducing smooth muscle cell apoptosis, suggesting a potential thermal therapy strategy to attenuate post-interventional restenosis.
Answers are grounded in this paper and cite their sources.
Supports targeted thermal therapy development for restenosis prevention; leaves open in vivo validation and clinical translation.
The fate of endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) is closely linked to the prevention of restenosis following vascular intervention. Localized thermal therapy enables precise targeting of proliferative tissue within diseased arterial walls; however, treatment duration is inherently limited to a few minutes because of the need for transient blood flow occlusion. Therefore, this study aimed to explore the optimal short-duration heating temperature for preserving ECs while suppressing VSMC proliferation, thereby guiding the optimization of localized thermal therapy parameters. The responses of ECs and VSMCs to short-duration heating (nominal temperatures of 37, 45, 50, and 55 °C for 2 min) were compared using cell and ex vivo tissue heating experiments. Adherent cell counting, immunofluorescence staining, and TUNEL assays were performed to quantitatively and qualitatively evaluate the outcomes. At 24 h, the adherent EC count in the 45 °C group was approximately 65.0% higher than that in the 37 °C control, without a statistically significant difference in Ki67 positivity. At 50 °C, adherent VSMC counts were reduced by 73.3% relative to the 37 °C control. Ex vivo tissue heating experiments revealed that heating at 45 °C had minimal impact on EC viability, whereas significant apoptosis occurred in the VSMCs at 50 °C. Therefore, spatially selective heating, targeting temperatures below 45 °C in the EC region and above 50 °C in the VSMC region, may offer a therapeutic strategy for attenuating post-interventional restenosis. Its feasibility, endothelial protective effects, and therapeutic efficacy require further thermal and functional validation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied Post-interventional restenosis. Short-duration localized heating vs. 37 °C control for 2 min was evaluated on Adherent endothelial cell and vascular smooth muscle cell counts, viability, and apoptosis at 24 hours. Short-duration heating for 2 min increased adherent endothelial cells by 65.0% at 45 °C and reduced adherent vascular smooth muscle cells by 73.3% at 50 °C vs 37 °C control.
Synapse has enriched 10 related papers. Consider them for comparative context: